![Efficacy and Safety of Vernakalant Hydrochloride Injection for the Treatment of Atrial Fibrillation After Valvular or Coronary Artery Bypass Surgery Peter. - ppt download Efficacy and Safety of Vernakalant Hydrochloride Injection for the Treatment of Atrial Fibrillation After Valvular or Coronary Artery Bypass Surgery Peter. - ppt download](https://images.slideplayer.com/23/6658440/slides/slide_5.jpg)
Efficacy and Safety of Vernakalant Hydrochloride Injection for the Treatment of Atrial Fibrillation After Valvular or Coronary Artery Bypass Surgery Peter. - ppt download
![PDF] Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus. Results of a post-hoc analysis from the randomized phase III ACT II trial. | Semantic Scholar PDF] Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus. Results of a post-hoc analysis from the randomized phase III ACT II trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5c1119f476e209b029798e1b0d4745a4d8e2393e/28-Table1-1.png)
PDF] Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus. Results of a post-hoc analysis from the randomized phase III ACT II trial. | Semantic Scholar
![Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial - The Lancet Oncology Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/5a0bed91-5e0a-42ce-994f-6dca82b33f4f/gr1_lrg.jpg)
Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial - The Lancet Oncology
![Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus: results of a post hoc analysis from the randomised phase III ACT II trial - ScienceDirect Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus: results of a post hoc analysis from the randomised phase III ACT II trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753420398999-gr1.jpg)
Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus: results of a post hoc analysis from the randomised phase III ACT II trial - ScienceDirect
![Trial procedures. AAQ-II, Acceptance and Action Questionnaire V.2; ACT,... | Download Scientific Diagram Trial procedures. AAQ-II, Acceptance and Action Questionnaire V.2; ACT,... | Download Scientific Diagram](https://www.researchgate.net/publication/352060229/figure/fig2/AS:1030241334087695@1622640083876/Trial-procedures-AAQ-II-Acceptance-and-Action-Questionnaire-V2-ACT-acceptance-and.jpg)
Trial procedures. AAQ-II, Acceptance and Action Questionnaire V.2; ACT,... | Download Scientific Diagram
![EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer. EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer.](https://christie.openrepository.com/bitstream/handle/10541/67983/elsevier-thumbnail.png?sequence=2&isAllowed=y)
EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer.
![Chemoradiation schedule used as a control arm in the ACT II trial as a... | Download Scientific Diagram Chemoradiation schedule used as a control arm in the ACT II trial as a... | Download Scientific Diagram](https://www.researchgate.net/publication/263296322/figure/fig2/AS:944785934282752@1602265928041/Chemoradiation-schedule-used-as-a-control-arm-in-the-ACT-II-trial-as-a-working-example-of_Q640.jpg)
Chemoradiation schedule used as a control arm in the ACT II trial as a... | Download Scientific Diagram
The Pirates of Penzance: Act II: Away, away! My heart's on fire (Pirate King, Ruth, Frederic) - song and lyrics by Arthur Sullivan | Spotify
![2021 – Long-term results from the phase II/III Act.In.Sarc trial evaluating NBTXR3 in locally advanced STS | Nano Publications 2021 – Long-term results from the phase II/III Act.In.Sarc trial evaluating NBTXR3 in locally advanced STS | Nano Publications](https://bibliography.nanobiotix.com/wp-content/uploads/2022/05/2021-oc-0210-long-term-results-from-the-phase-ii-iii-act-in-sarc-trial-evaluating-nbtxr3-in-locally-advanced-sts.png)
2021 – Long-term results from the phase II/III Act.In.Sarc trial evaluating NBTXR3 in locally advanced STS | Nano Publications
![Dr Mark Saunders Christie Hospital and Paterson Institute of Cancer Research “Anal cancer chemoradiotherapy” - ppt download Dr Mark Saunders Christie Hospital and Paterson Institute of Cancer Research “Anal cancer chemoradiotherapy” - ppt download](https://images.slideplayer.com/24/7358100/slides/slide_13.jpg)
Dr Mark Saunders Christie Hospital and Paterson Institute of Cancer Research “Anal cancer chemoradiotherapy” - ppt download
![2021 – Long-term evaluation of the novel radioenhancer NBTXR3 plus radiotherapy in patients with locally advanced soft tissue sarcoma treated in the phase II/III Act.In.Sarc trial | Nano Publications 2021 – Long-term evaluation of the novel radioenhancer NBTXR3 plus radiotherapy in patients with locally advanced soft tissue sarcoma treated in the phase II/III Act.In.Sarc trial | Nano Publications](https://bibliography.nanobiotix.com/wp-content/uploads/2022/05/2021-long-term-evaluation-of-the-novel-radioenhancer-nbtxr3-plus-radiotherapy-in-patients-with-locally-advanced-soft-tissue-sarcoma-treated-in-the-phase-ii-iii-act-in-sarc-trial.png)
2021 – Long-term evaluation of the novel radioenhancer NBTXR3 plus radiotherapy in patients with locally advanced soft tissue sarcoma treated in the phase II/III Act.In.Sarc trial | Nano Publications
![Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial - The Lancet Oncology Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/30045e5f-3478-496d-895f-8bc742515cf7/gr1.gif)